U.S. Tobacco Stock News

Big Tech’s push to keep an estimated US$300b of AI exposure off balance sheets has created a huge buildout of data centres and chips, but also fresh questions about how sustainable that spending really is. That mix of ambition and scrutiny puts more focus on fast expanding businesses where insiders have meaningful skin in the game. This article breaks down three such high conviction growth stocks from our screener. The stocks covered below are only a small sample, and the full screen surfaced...

Pathward Financial (CASH) just reported a leadership change, with President Anthony Sharett resigning effective October 23, 2026. He previously served in senior legal and compliance roles at the bank and its Pathward, N.A. subsidiary. Recent trading has been softer, with Pathward Financial’s share price down 8.97% over the past month and 7.70% over the last 90 days. However, the year-to-date share price return of 5.98% and a 3-year total shareholder return of 67.36% highlight momentum that...

How the MIUDELLA update ties into Organon’s women’s health focus Organon (OGN) is back in focus after the FDA accepted a filing to extend the approved duration of use for MIUDELLA, a copper intrauterine system that Organon licensed globally in 2026. The sNDA seeks to stretch labeled use to 6 years from 3 years, with a PDUFA decision expected in the second quarter of 2027. That timing matters for investors who are monitoring the potential evolution of Organon’s women’s health line. Organon’s...

Big Tech’s heavy use of off balance sheet guarantees for AI data centres has pushed huge sums into projects that still need earnings to catch up. That kind of uncertainty puts a spotlight on businesses where analysts see solid profit growth potential and balance sheets that look reasonably robust. This article walks through three stocks from a high quality growth screener that filters for both factors. The three stocks below are just a small sample, and the full screen surfaced 1,570 more...

T-Mobile US (TMUS) is back in focus after a sharp 5.6% slide on 17 September to about $166. Richer iPhone 18 promotions and plan repricing are raising fresh questions about future wireless profitability. For context, T-Mobile US shares are at about US$168.18 after that recent drop, with the 1-week and 30-day share price returns down 7.8% and 8.1%. The 1-year total shareholder return has declined 27.9%, while the 3 and 5-year total shareholder returns of 26.9% and 36.7% suggest that...

Photronics (PLAB) has now wrapped up a multi year share repurchase effort, confirming on 10 September 2026 that it completed buying back 12,646,808 shares for US$165.98m under its 2020 authorization. At a share price of US$29.11, Photronics has seen its short term share price weaken, with the 90 day share price return down 14.53% and the year to date share price return down 12.87%, even as the 5 year total shareholder return of 106.45% points to much stronger long run compounding. Scan beyond...

UMB Financial (UMBF) has attracted attention after recent share price moves, with the stock closing at US$134.52. Investors are considering its performance over the past month and past 3 months in relation to its longer term returns. Recent trading has been choppy, with the share price down 7.32% over the past 30 days and 3.56% over the past week. Even so, UMB Financial still shows a 15.49% year to date share price gain and a 130.99% three year total shareholder return, which points to longer...

WillScot Holdings (WSC) is back on investor screens after its recent quarter showed revenue and earnings per share coming in ahead of analyst expectations, driven by modular unit activations and a firm order book. Recent trading tells a very different story to the latest quarterly beat. WillScot Holdings has seen its share price slip sharply, with the 30 day share price return down 17.9% and the 90 day share price return down 37.4%. The 1 year total shareholder return has fallen 18.4%,...

The Fed just nudged rates up to 3.75% to 4%, and that small move reshuffles the math for every U.S. consumer bank and credit card issuer you track. Higher borrowing costs can strain household budgets, yet they also change how interest income flows through lenders like the ones in this screener. This article walks through 3 stocks most exposed to that news, and shows how each could either help or hurt your portfolio story. The three stocks that follow are just a sample from this rate sensitive...

Harley-Davidson (HOG) is back in the headlines after reuniting with Realtree for a second limited-edition apparel collection, a merchandising move that arrives shortly after a softer week for the stock. That Realtree drop lands at a time when Harley-Davidson’s share price has cooled in the short term, with a 7-day share price return down 6.96% and a 30-day share price return down 8.05%, even after a 25.63% year-to-date gain and a weaker 1-year total shareholder return that has declined 5.37%...

Ultragenyx Pharmaceutical (RARE) is back in focus after the U.S. Food and Drug Administration granted standard full approval for FAYUVI, a gene therapy for children with Sanfilippo syndrome Type A. Despite the positive headline, Ultragenyx Pharmaceutical’s recent trading tells a more complicated story. The share price is around US$14.51 after a sharp 30 day decline of about 44% and a 90 day slide of roughly 50%, while the 1 year total shareholder return is down about 48%. Short term traders...

Some Scorpio Tankers Inc. ( NYSE:STNG ) shareholders may be a little concerned to see that the President & Director...

NovoCure reported that long serving director Timothy Scannell retired from the Board on 2 September 2026, with the company stating his departure after five years did not stem from any dispute with management. Management also laid out a refreshed operating roadmap that concentrates on rekindling glioblastoma device demand, broadening pancreatic and lung cancer launches, and working toward adjusted EBITDA break-even by year-end. We will look at how NovoCure's investment narrative is reshaped...

Magnite (MGNI) is trying to reset how ad buying works. The latest updates to its Orchestration platform link AI agents across TV, audio, display, and video, while fresh partnerships test that pitch in real campaigns. These product moves are landing against a busy tape for Magnite. The share price has climbed 44.13% over the past 90 days and 56.60% year to date, yet the 1 year total shareholder return is still down 2.97%. Momentum has picked up recently, but the longer record remains...

Innodata (INOD) has added Admiral Michael S. Rogers, the former head of the NSA and U.S. Cyber Command, to its board. His appointment brings high-profile cyber expertise to support the company's AI safety initiatives and Federal-focused ambitions. Innodata’s share price has been volatile, with a 7.4% gain over the past week, a 37% decline over the last 90 days, and a 19% fall in 1-year total shareholder return, even though 3-year and 5-year total shareholder returns remain very large...

Cleveland-Cliffs confirmed a US$1b modernization program for its Middletown Works plant in Ohio, backed by a US$500m U.S. Department of Energy grant and scheduled over four years while production continues. The Middletown upgrade focuses on addressing aging, carbon intensive assets and aims to improve efficiency, reliability, and the sustainability profile of a key U.S. steel facility. We will examine how Cleveland-Cliffs' investment story is influenced by this US$1b Middletown modernization...

NIQ Global Intelligence (NIQ) just rolled out its Digital Purchase GeoAudiences tool across five major European markets, giving advertisers fresh purchase based signals tied to real digital shopping behavior. NIQ Global Intelligence has been on a sharp run recently, with a 90 day share price return of 126.81% and a year to date gain of 15.27%. However, the 1 year total shareholder return is a more modest 6.62%, suggesting the recent momentum reflects shifting expectations around its new...

Galaxy Digital (GLXY) has reshuffled a key investor-facing role by appointing Taylor Reinhardt as Head of Investor Relations and moving Jonathan Goldowsky into a Co-Head of Europe position. For investors tracking Galaxy Digital, the latest investor relations reshuffle comes after a sharp 1-day share price return of 10.8% and a 90-day share price decline of 25.5%. Over the past three years, the total shareholder return is roughly 7x, while the 1-year total shareholder return is down 24.9%,...

Trade talks between Washington and Beijing are circling around AI, tariffs and critical minerals, and that puts U.S.-listed rare-earth and battery material stocks under a bright spotlight. When rules of the game are up for debate, capital often moves first and asks questions later. This article walks through three stocks from our Critical Minerals and Rare-Earth Supply Security Plays screener that appear most exposed to the latest headlines and explains why that exposure might matter for your...

Leadership change at Otis Worldwide Otis Worldwide (OTIS) has put succession planning in the spotlight after announcing that long-serving Chair, President, and CEO Judy Marks will retire once a new chief executive is appointed. The board has started a CEO search that includes internal and external candidates, with Marks expected to support the handover as needed to keep the business and its elevator and escalator franchise running without disruption. Recent trading has been softer, with the...

We wouldn't blame Revvity, Inc. ( NYSE:RVTY ) shareholders if they were a little worried about the fact that Tajinder...

Some Aflac Incorporated ( NYSE:AFL ) shareholders may be a little concerned to see that the President and...

Rockwell Automation (ROK) has joined Anthropic’s Project Glasswing, giving its security teams controlled access to Claude Mythos 5 to probe vulnerabilities in industrial software and connected manufacturing systems that support critical infrastructure. Recent trading shows some cooling in Rockwell Automation’s momentum, with the share price down 4.91% over the past 30 days and 13.06% over 90 days, even as the year-to-date share price return is 4.28% and the 1-year total shareholder return...

National HealthCare (NHC) has been drawing fresh attention after a recent move in its valuation metrics, with investors weighing a market value of about US$3.48b against its current fundamentals. Recent trading has cooled slightly, with the share price down 4.84% over the past month. Even so, National HealthCare still carries a 10.28% 90 day share price gain and a very strong 92.74% 1 year total shareholder return, which points to momentum that has been building rather than fading as...